Coblopasvir

Coblopasvir (KW136, KW-136) is a novel HCV NS5A inhibitor under development for treatment of HCV infection.

Target : HCV

CAS Number : 1312608-46-0

Formula Weight : 782.899

Molecular Formula : C41H50N8O8

Purity : >98% (HPLC)

Storage : (-20?)

Shipping Conditions : With Ice Pack

Stability : ? 2 years

Research use only, not for human use.